ZVRA
Zevra Therapeutics Inc.
11.70$
+0.5%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | +3.5% | +115.6% | -64.5% | +170.3% | -14.0% | +350.9% | |
| – | – | +108.3% | +92.0% | -3.6% | +809.0% | -55.7% | +57.8% | -89.2% | +1,226.6% | +151.9% | +122.2% | |
| – | – | – | – | – | – | +21.1% | +121.9% | -62.6% | +146.7% | -33.9% | +455.7% | |
| – | +16.9% | +47.0% | +0.6% | +102.8% | -53.5% | -54.5% | +14.9% | +94.9% | +101.0% | +5.8% | -69.7% | |
| – | +96.3% | +57.6% | -8.8% | -2.1% | -13.5% | -26.8% | +9.8% | +76.3% | +61.2% | +121.8% | +41.5% | |
| – | +38.7% | +51.1% | -3.2% | +62.6% | -44.3% | -41.8% | +7.2% | +178.4% | +41.2% | +39.2% | -8.7% | |
| – | – | – | – | – | – | – | – | -650.7% | – | – | – | |
| – | -1.6% | +166.8% | +2.9% | -3.4% | -8.1% | +8.8% | -94.7% | -10.9% | +348.1% | +389.7% | +8.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -157.7% | – | – | – | – | – | -197.1% | – | – | -77.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.